BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

352 related articles for article (PubMed ID: 17503565)

  • 21. A critical analysis of the value of simultaneous inferior petrosal sinus sampling in Cushing's disease and the occult ectopic adrenocorticotropin syndrome.
    Kaltsas GA; Giannulis MG; Newell-Price JD; Dacie JE; Thakkar C; Afshar F; Monson JP; Grossman AB; Besser GM; Trainer PJ
    J Clin Endocrinol Metab; 1999 Feb; 84(2):487-92. PubMed ID: 10022405
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Assessment of cortisol and ACTH responses to the desmopressin test in patients with Cushing's syndrome and simple obesity.
    Tsagarakis S; Vasiliou V; Kokkoris P; Stavropoulos G; Thalassinos N
    Clin Endocrinol (Oxf); 1999 Oct; 51(4):473-7. PubMed ID: 10583315
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Importance of the CRH (corticotropin releasing hormone) test in the differential diagnosis of Cushing's syndrome].
    Korsić M; Plavsić V; Besenski N; Skorić T; Giljević Z; Zarković K; Zarković N; Zaninović L; Paladino J; Aganović I
    Lijec Vjesn; 2001; 123(7-8):165-8. PubMed ID: 11729609
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A reappraisal of the ovine corticotropin-releasing hormone stimulation test in the differential diagnosis of Cushing's syndrome: a comparison with the standard high-dose dexamethasone suppression test.
    Lee TI; Lin SY; Won JG; Tang KT; Jap TS; Kwok CF; Lin HD
    Zhonghua Yi Xue Za Zhi (Taipei); 2002 Oct; 65(10):474-82. PubMed ID: 12523812
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Desmopressin test during petrosal sinus sampling: a valuable tool to discriminate pituitary or ectopic ACTH-dependent Cushing's syndrome.
    Castinetti F; Morange I; Dufour H; Jaquet P; Conte-Devolx B; Girard N; Brue T
    Eur J Endocrinol; 2007 Sep; 157(3):271-7. PubMed ID: 17766708
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The ovine corticotropin-releasing hormone stimulation test and the dexamethasone suppression test in the differential diagnosis of Cushing's syndrome.
    Nieman LK; Chrousos GP; Oldfield EH; Avgerinos PC; Cutler GB; Loriaux DL
    Ann Intern Med; 1986 Dec; 105(6):862-7. PubMed ID: 3022629
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Differentiating between Cushing's disease and pseudo-Cushing's syndrome: comparison of four tests.
    Alwani RA; Schmit Jongbloed LW; de Jong FH; van der Lely AJ; de Herder WW; Feelders RA
    Eur J Endocrinol; 2014 Apr; 170(4):477-86. PubMed ID: 24394725
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A very high dose dexamethasone suppression test for differential diagnosis of Cushing's syndrome.
    al-Saadi N; Diederich S; Oelkers W
    Clin Endocrinol (Oxf); 1998 Jan; 48(1):45-51. PubMed ID: 9509067
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Discriminatory value of the low-dose dexamethasone suppression test in establishing the diagnosis and differential diagnosis of Cushing's syndrome.
    Isidori AM; Kaltsas GA; Mohammed S; Morris DG; Jenkins P; Chew SL; Monson JP; Besser GM; Grossman AB
    J Clin Endocrinol Metab; 2003 Nov; 88(11):5299-306. PubMed ID: 14602765
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The use of the corticotropin-releasing hormone test to monitor the recovery of patients with Cushing's disease or Cushing's syndrome due to an adrenal adenoma after adenomectomy.
    Hotta MN; Shibasaki T; Suda T; Ling N; Shizume K
    Endocrinol Jpn; 1985 Feb; 32(1):113-25. PubMed ID: 2990881
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A comparison of the effects of human and ovine corticotropin-releasing hormone on the pituitary-adrenal axis.
    Trainer PJ; Faria M; Newell-Price J; Browne P; Kopelman P; Coy DH; Besser GM; Grossman AB
    J Clin Endocrinol Metab; 1995 Feb; 80(2):412-7. PubMed ID: 7852498
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Responsivity of adrenocorticotropin to corticotropin-releasing hormone and lack of suppressibility by dexamethasone are related phenomena in Cushing's disease.
    Hermus AR; Pieters GF; Pesman GJ; Smals AG; Benraad TJ; Kloppenborg PW
    J Clin Endocrinol Metab; 1986 Apr; 62(4):634-9. PubMed ID: 3005353
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Ovine CRH Stimulation and 8 mg Dexamethasone Suppression Tests in 323 Patients With ACTH-Dependent Cushing's Syndrome.
    Elenius H; McGlotten R; Nieman LK
    J Clin Endocrinol Metab; 2023 Dec; 109(1):e182-e189. PubMed ID: 37531629
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Usefulness of the desmopressin test in the postoperative evaluation of patients with Cushing's disease.
    Colombo P; Dall'Asta C; Barbetta L; Re T; Passini E; Faglia G; Ambrosi B
    Eur J Endocrinol; 2000 Aug; 143(2):227-34. PubMed ID: 10913942
    [TBL] [Abstract][Full Text] [Related]  

  • 35. How early can one diagnose Cushing's disease? An early diagnosis in a case of prepubertal Cushing's disease.
    Hoppmann J; Wagner IV; Junghans G; Wudy SA; Buchfelder M; Hirsch FW; Ritter L; Kiess W; Pfäffle R
    J Pediatr Endocrinol Metab; 2014 Nov; 27(11-12):1043-7. PubMed ID: 25367688
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Adrenocorticotropin- and cortisol-releasing effect of hexarelin, a synthetic growth hormone-releasing peptide, in normal subjects and patients with Cushing's syndrome.
    Ghigo E; Arvat E; Ramunni J; Colao A; Gianotti L; Deghenghi R; Lombardi G; Camanni F
    J Clin Endocrinol Metab; 1997 Aug; 82(8):2439-44. PubMed ID: 9253314
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Outcome of CRH stimulation test and overnight 8 mg dexamethasone suppression test in 469 patients with ACTH-dependent Cushing's syndrome.
    Detomas M; Ritzel K; Nasi-Kordhishti I; Wolfsberger S; Quinkler M; Losa M; Tröger V; Kroiss M; Fassnacht M; Vila G; Honegger JB; Reincke M; Deutschbein T
    Front Endocrinol (Lausanne); 2022; 13():955945. PubMed ID: 36277711
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Evaluation of the accuracy of inferior petrosal sinus sampling in the differential diagnosis of ACTH-dependent Cushing's syndrome].
    Tóth M; Vajda Z; Görömbey Z; Molnár F; Major L; Toke J; Szabolcs I; Szücs N; Kovács L; Kiss R; Czirják S; Füto L; Gláz E; Góth M; Rácz K
    Orv Hetil; 2007 May; 148(18):843-7. PubMed ID: 17468067
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Ectopic adrenocorticotropic hormone and corticotropin-releasing hormone co-secreting tumors in children and adolescents causing cushing syndrome: a diagnostic dilemma and how to solve it.
    Karageorgiadis AS; Papadakis GZ; Biro J; Keil MF; Lyssikatos C; Quezado MM; Merino M; Schrump DS; Kebebew E; Patronas NJ; Hunter MK; Alwazeer MR; Karaviti LP; Balazs AE; Lodish MB; Stratakis CA
    J Clin Endocrinol Metab; 2015 Jan; 100(1):141-8. PubMed ID: 25291050
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The differential diagnosis of Cushing's syndrome.
    Newell-Price J; Grossman AB
    Ann Endocrinol (Paris); 2001 Apr; 62(2):173-9. PubMed ID: 11353890
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.